US 12,110,518 B2
Polypeptides
Ming Li, Beijing (CN); Jesper Salomon, Holte (DK); Dorotea Raventos Segura, Rungsted (DK); Mary Ann Stringer, Soborg (DK); Rebecca Munk Vejborg, Allerod (DK); Dorte Marie Koefoed Klitgaard, Birkerod (DK); Dorota Nissen, Bagsvaerd (DK); Wei Peng, Bagsvaerd (DK); and Tianqi Sun, Beijing (CN)
Assigned to Novozymes A/S, Bagsvaerd (DK)
Appl. No. 17/051,454
Filed by Novozymes A/S, Bagsvaerd (DK)
PCT Filed May 30, 2019, PCT No. PCT/CN2019/089237
§ 371(c)(1), (2) Date Oct. 29, 2020,
PCT Pub. No. WO2019/228448, PCT Pub. Date Dec. 5, 2019.
Claims priority of application No. 18175572 (EP), filed on Jun. 1, 2018.
Prior Publication US 2021/0163852 A1, Jun. 3, 2021
Int. Cl. C12N 9/26 (2006.01); C11D 3/00 (2006.01); C11D 3/386 (2006.01); C12N 9/24 (2006.01)
CPC C12N 9/2402 (2013.01) [C11D 3/0036 (2013.01); C11D 3/38636 (2013.01); C11D 3/38672 (2013.01); C11D 2111/12 (2024.01); C12Y 302/01109 (2013.01)] 15 Claims
OG exemplary drawing
 
1. A cleaning composition comprising:
(a) at least 0.01 ppm GH114 glycosyl hydrolase having alpha-1,4-polygalactosaminidase activity, wherein the GH114 glycosyl hydrolase comprises one or both motif(s) [VLI]XE[EDSQ]C (SEQ ID NO: 60) or CY[FLIV][SDN][ATVG] (SEQ ID NO: 61) and has at least 85% sequence identity to SEQ ID NO: 18; and
(b) an anionic surfactant selected from the group consisting of sulfates and sulfonates.